The Elecsys ApoE4 test is the first CE marked in-vitro diagnostic immunoassay to identify individuals carrying the ApoE4 genetic variant using a simple blood sample. The test offers a fast, reliable and accessible option to rapidly differentiate between carriers and non-carriers. The test...
Hence then, the article about roche receives ce mark for first ivd immunoassay blood test to identify carriers of apoe4 a genetic variant present in up to 60 of patients diagnosed with alzheimer s disease was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease )
Also on site :
- Garth Brooks’ Daughter Receives Backlash for Her Dolly Parton Tribute
- Dollywood CEO Makes One Thing Clear About the Park After Dolly Parton’s Death
- 1975 Folk Rock Hit, Inspired by Bob Dylan’s Marriage, Ranked Among ‘Best Rock Love Songs’ of All Time